CrushSCI.com
171.6Average days
156Median days
55Fastest days
285Longest days
1102025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

89 days

Rozanolixizumab: A Review in AChR or MuSK Autoantibody-Positive Generalised Myasthenia Gravis

Authors
Aisling McGuigan; Hannah A. BlairShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
Source PDF DOI Publisher page
285 days

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials

Authors
Itai Danovitch; Kyla Truman; Haze Brown; Macie Miller; Shaishav Shah; Jayant Totlani; Daniel N. Kaidbay; Kaleab K. Tessema; Zholi Minasyan; Waguih William IsHak; Samuel Miles; Robert N. PechnickShow moreShow less
Affiliations
1. Department of Psychiatry, Cedars-Sinai Health Sciences University, Los Angeles, USA; 2. David Geffen School of Medicine at UCLA, Los Angeles, USA; 3. Virginia Commonwealth University Health System, Richmond, USA; 4. Western University of Health Sciences, Pomona, USAShow moreShow less
Source PDF DOI Publisher page
117 days

Bistromathics in Epilepsy and the Relativity of Numbers

Authors
Emilio Russo; Roberta Roberti; Eugen TrinkaShow moreShow less
Affiliations
1. Science of Health Department, CRUISE Research Center, University Magna Grecia of Catanzaro, Catanzaro, Italy; 2. Department of Neurology, Neurocritical Care and Neurorehabilitation, Member of EpiCARE, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria; 3. Neuroscience Institute, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria; 4. Karl Landsteiner Institute for Clinical Neurosciences, Salzburg, AustriaShow moreShow less
Source PDF DOI Publisher page
156 days

Cognitive Side Effects of Antiseizure Medications in Adults with Epilepsy: An Update with a Focus on New Therapeutic Agents

Authors
Marco MulaShow moreShow less
Affiliations
1. Department of Neurology, Atkinson Morley Regional Neuroscience Centre, St George’s University Hospitals, London, UKShow moreShow less
Source PDF DOI Publisher page
160 days

Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms

Authors
Alana King; Morgan Hardy; Taeho Greg Rhee; Samuel T. WilkinsonShow moreShow less
Affiliations
1. Department of Psychiatry, Yale University, New Haven, USAShow moreShow less
Source PDF DOI Publisher page
55 days

Emerging Pharmacological Strategies for Trigeminal Neuralgia

Authors
Juliana Geremias Chichorro; Victor Augusto Benedicto dos Santos; Gerald W. ZamponiShow moreShow less
Affiliations
1. Department of Pharmacology, Biological Sciences Sector, Federal University of Parana, Curitiba, Brazil; 2. Department of Clinical Neurosciences, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, CanadaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CNS DRUGS take to review a manuscript?

As of 2026-11-18, CrushSCI has 15 complete review records for CNS DRUGS. The fastest paper went from submission to acceptance in 55 days (Emerging Pharmacological Strategies for Trigeminal Neuralgia, received 2026-04-02, accepted 2026-05-27); the slowest took 285 days. The average is 171.6 days and the median is 156 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.